<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JNC</journal-id>
<journal-title-group>
<journal-title>Journal of Neurocritical Care</journal-title><abbrev-journal-title>J Neurocrit Care</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">2005-0348</issn>
<issn pub-type="epub">2508-1349</issn>
<publisher>
<publisher-name>Korean Neurocritical Care Society</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.18700/jnc.230018</article-id>
<article-id pub-id-type="publisher-id">jnc-230018</article-id>
<article-categories>
<subj-group>
<subject>Case Report</subject></subj-group></article-categories>
<title-group>
<article-title>Concomitant moyamoya syndrome and infratentorial arteriovenous malformation in a neurofibromatosis type 1 patient: a case report</article-title>
<alt-title alt-title-type="right-running-head">Moyamoya syndrome and AVM in NF 1</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6173-453X</contrib-id>
<name><surname>Ko</surname><given-names>Eunbuel</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-jnc-230018"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0002-8827-1173</contrib-id>
<name><surname>Hwang</surname><given-names>Il-Jung</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-jnc-230018"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0000-0482-0266</contrib-id>
<name><surname>Kim</surname><given-names>Jung-Woo</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-jnc-230018"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7303-3626</contrib-id>
<name><surname>Lee</surname><given-names>Ju-Suck</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-jnc-230018"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0008-9843-446X</contrib-id>
<name><surname>Jung</surname><given-names>Dar-Eun</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-jnc-230018"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7988-0228</contrib-id>
<name><surname>Yoo</surname><given-names>Sang-Won</given-names></name>
<degrees>MD</degrees><degrees>PhD</degrees>
<xref ref-type="corresp" rid="c1-jnc-230018"/>
<xref ref-type="aff" rid="af1-jnc-230018"/>
</contrib>
<aff id="af1-jnc-230018">
Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-jnc-230018">Corresponding author: Sang-Won Yoo, MD, PhD Department of Neurology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-6732 Fax: +82-2-2258-2817 E-mail: <email>hiswy83@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2023</year></pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>6</month>
<year>2023</year></pub-date>
<volume>16</volume>
<issue>1</issue>
<fpage>39</fpage>
<lpage>42</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>05</month>
<year>2023</year></date>
<date date-type="rev-recd">
<day>9</day>
<month>06</month>
<year>2023</year></date>
<date date-type="accepted">
<day>20</day>
<month>06</month>
<year>2023</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 The Korean Neurocritical Care Society</copyright-statement>
<copyright-year>2023</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract>
<sec><title>Background</title>
<p>Neurofibromatosis type 1 (NF1) is a genetic disorder with diverse phenotypic manifestations. Cerebral vasculopathy is one of the multisystem involvements often overlooked unless symptomatic. </p></sec>
<sec><title>Case Report</title>
<p>A 28-year-old male patient with prolonged NF1 complained of right-hand position-specific rhythmic tremor after surviving an ipsilateral cerebellar arteriovenous malformation (AVM) hemorrhagic transformation. Not only did he suffer rupture of the infratentorial vasculopathy but he also endured asymmetric supratentorial occlusive vessel changes in moyamoya syndrome. Due to contralateral limb clumsiness, his right hemispheric vasculature was revascularized by encephaloduroarteriosynangiosis 13 years before the AVM rupture.</p></sec>
<sec><title>Conclusion</title>
<p>This case report describes exceptional NF1 central nervous system involvement where the cerebral vasculature had concomitant moyamoya syndrome and unilateral cerebellar AVM in a single patient. Cerebral vasculopathy should be surveyed and adequately addressed during the follow-up of chronic NF1, as it can cause irreversible sequelae or can be life-threatening.</p></sec>
</abstract>
<kwd-group>
<kwd>Neurofibromatosis 1</kwd>
<kwd>Intracranial arterial diseases</kwd>
<kwd>Cerebrovascular disorders</kwd>
</kwd-group>
</article-meta></front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder involving multiple organs, with variable phenotypes. It develops sporadically without a family history in approximately half of the patients &#x0005b;<xref ref-type="bibr" rid="b1-jnc-230018">1</xref>&#x0005d;. Central nervous system vasculopathy in patients with NF1 is associated with diverse clinical manifestations. Cerebral arteriopathies, including steno-occlusion, ectasia, and aneurysmal changes, have been reported in the literature, but their prevalence has not been estimated &#x0005b;<xref ref-type="bibr" rid="b1-jnc-230018">1</xref>,<xref ref-type="bibr" rid="b2-jnc-230018">2</xref>&#x0005d;.</p>
<p>Not only is it rare to encounter moyamoya-like vessel changes in patients with NF1, but it is also exceptional to observe concomitant arteriovenous malformations (AVMs) in the remaining infratentorial vasculature. Herein, we report a case of contradictory occlusive and excessive intracranial vasculopathy in a single patient with NF1.</p>
</sec>
<sec sec-type="cases">
<title>CASE REPORT</title>
<p>A 28-year-old man visited our neurological clinic with involuntary movements of his right arm which lasted for 3 months. He described oscillating rhythmic right hand tremors. It started after he survived the rupture of an ipsilateral cerebellar AVM involving the cerebellopontine area. His medical history revealed that he had NF1 since he was 10 years old. His diagnosis was supported by multiple hyperpigmented brownish macules measuring &gt;15 mm (caf&#x000e9;-au-lait spots), and axillary/inguinal freckles. He endured one or two episodes of infrequent afebrile epileptic seizures per year until the age of 9, which regressed spontaneously. His intellectual ability lagged slightly behind that of his peers and he manifested an attentional deficit without social incompetence. His motor development was not delayed; however, he appeared to be shorter than his age-average height. At 28 years old, his size reached 164 cm.</p>
<p>At the age of 15, 13 years before the AVM rupture, he reported clumsiness and awkwardness of left limb movements. He was diagnosed with asymmetric moyamoya syndrome (Suzuki grades III and VI in the left and right hemispheres, respectively (<xref rid="f1-jnc-230018" ref-type="fig">Fig. 1A</xref> and <xref rid="f1-jnc-230018" ref-type="fig">B</xref>) and right cerebellar AVM. The right posterior inferior cerebellar artery (PICA) mainly supplied the vascular tuft, which drained into the sigmoid sinus (<xref rid="f1-jnc-230018" ref-type="fig">Fig. 1C</xref>). A Suzuki grade VI in the right hemisphere was presumed to be the cause of the patient&#x02019;s symptoms. Right superficial temporal artery to middle cerebral artery bypass was performed to revascularize the right hemispheric vasculature. The infratentorial AVM was not intervened at the time. After the surgery, the patient stopped experiencing left appendicular symptoms. The bypass conduit was maintained for 13 years (<xref rid="f1-jnc-230018" ref-type="fig">Fig. 1D</xref>).</p>
<p>Neither his parents nor brother were diagnosed with any neurological disease. The patient was not taking any medications that might have provoked his unilateral tremor. Right upper and lower limb ataxia were observed on neurological examination. The motor power of the extremities was graded as the Medical Research Council 5. The patient was unstable on foot and required assistance while walking. His right hand tremors had a rhythmic supination-pronation nature within 2&#x02013;4 Hz when his hand rested in the mid-position between supination and pronation. The Mini-Mental Status Examination score was 23/30, revealing global cognitive impairment. However, he had the total capacity to engage in conversations and respond to commands. Serological assessment, including copper metabolism, revealed no metabolic derangement relevant to the tremor. Ophthalmological evaluation did not reveal any copper deposits.</p>
<p>Six months before the tremors, the right cerebellar AVM had ruptured. The right anterior and posterior inferior cerebellar arteries (AICA and PICA) and superior cerebellar artery supplied the AVM. The AICA and superior cerebellar artery feeders were successfully embolized, whereas the PICA was partially blocked with remaining residual flow (<xref rid="f2-jnc-230018" ref-type="fig">Fig. 2A</xref> and <xref rid="f2-jnc-230018" ref-type="fig">B</xref>). The extant PICA was not intervened further because its flow velocity significantly decreased and other feeders were blocked. Regular follow-ups were planned to monitor for any changes. Brain magnetic resonance imaging at rupture and at follow-up (<xref rid="f2-jnc-230018" ref-type="fig">Fig. 2C</xref> and <xref rid="f2-jnc-230018" ref-type="fig">D</xref>) revealed edematous hemorrhage in the cerebellum/cerebellar peduncles and incomplete regression, respectively.</p>
<p>After 6 months of follow-up, his position-specific tremors persisted despite improvement in his limb ataxia. The patient could walk independently with his feet wide. Although his tremors did not disappear, they did not interfere with his daily activities of living, and ataxia rehabilitation was maintained without any medication.</p>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>NF1 is a multisystem disease with diverse progression and severity throughout life &#x0005b;<xref ref-type="bibr" rid="b3-jnc-230018">3</xref>&#x0005d;. Phenotypic variants occur across multiple organs and represent structural and/or functional deficits &#x0005b;<xref ref-type="bibr" rid="b3-jnc-230018">3</xref>-<xref ref-type="bibr" rid="b6-jnc-230018">6</xref>&#x0005d;. Its diagnosis can be postponed when an affected individual without a known family history presents only with skin hyperpigmentation and later develops other signs that fulfill the diagnostic criteria &#x0005b;<xref ref-type="bibr" rid="b1-jnc-230018">1</xref>,<xref ref-type="bibr" rid="b3-jnc-230018">3</xref>&#x0005d;. The patient&#x02019;s diagnosis of NF1 was delayed at 10 years of age because other non-skin manifestations, such as intellectual/attentional deficits and below-average stature, became apparent later and indicated its suspicion.</p>
<p>Five years after his diagnosis, asymmetric moyamoya syndrome was identified, and the symptomatic hemispheric vasculature was rescued by bypass surgery. Although cerebral arteriopathy is rarely reported, NF1 is associated with cerebrovascular abnormalities in the adult and pediatric populations &#x0005b;<xref ref-type="bibr" rid="b1-jnc-230018">1</xref>&#x0005d;. Moyamoya syndrome is one of its subtypes with higher risk of ischemic or hemorrhagic stroke than in the general population &#x0005b;<xref ref-type="bibr" rid="b2-jnc-230018">2</xref>,<xref ref-type="bibr" rid="b7-jnc-230018">7</xref>&#x0005d;. Right hemispheric ischemia caused by asymmetric steno-occlusive intracranial cerebral vessels (more severe on the right) was interpreted as evoking left appendicular awkwardness when demanding execution was required. The patient&#x00027;s infrequent epileptic seizures, which resolved spontaneously, could also be explained by cerebral vasculopathy. Hemodynamic insufficiency could have occasionally kindled epileptogenic firing above the threshold, which disappeared after rescue surgery.</p>
<p>Ecstatic or aneurysmal vasculopathy associated with NF1 has been investigated in a systemic review, but infratentorial AVM has seldom been reported, let alone concomitant cerebrovascular abnormalities in a single NF1 individual &#x0005b;<xref ref-type="bibr" rid="b2-jnc-230018">2</xref>-<xref ref-type="bibr" rid="b4-jnc-230018">4</xref>,<xref ref-type="bibr" rid="b8-jnc-230018">8</xref>,<xref ref-type="bibr" rid="b9-jnc-230018">9</xref>&#x0005d;. The pathomechanism underlying cerebrovascular disease is poorly understood &#x0005b;<xref ref-type="bibr" rid="b1-jnc-230018">1</xref>&#x0005d;. The coexistence of opposing vasculopathies (occlusive vs. hyperplastic) may be a coincidence. However, simultaneous observations of advanced moyamoya syndrome and a large infratentorial AVM in childhood, which affected approximately three-quarters of all intracranial vessels, suggested that the chronic pathobiology of NF1 took place for a prolonged time and played a role in its vasculopathy.</p>
<p>The position-specific tremor associated with limb ataxia was ipsilateral to the AVM rupture. The exact pathomechanism remains elusive, but its time-locked appearance after hemorrhage implies that the destruction of a central oscillator network, such as the Guillain-Mollaret triangle, may have caused its hyperkinetic movements &#x0005b;<xref ref-type="bibr" rid="b10-jnc-230018">10</xref>&#x0005d;. Cerebral vasculopathy is a consistent and relevant manifestation of NF1 and can take variable forms with extensive involvement, even in early childhood, as seen in this case report. Its prevalence and natural history are unknown because active screening for cerebrovascular diseases is not routinely performed &#x0005b;<xref ref-type="bibr" rid="b2-jnc-230018">2</xref>&#x0005d;. Approximately 44.5% of NF1 patients who demonstrated vascular abnormalities were asymptomatic, emphasizing the need for early screening and not waiting for symptoms to emerge &#x0005b;<xref ref-type="bibr" rid="b2-jnc-230018">2</xref>&#x0005d;.</p>
<p>In summary, we report a case of chronic NF1 with extensive concomitant opposing cerebral vasculopathy. Investigations and interventions for cerebrovascular disease were only performed when the patient became symptomatic. The overall annual rate of AVM rupture is estimated to be 2.3% (1.3% for unruptured vs. 4.8% for ruptured AVM), and specific genes increase the risk of rupture &#x0005b;<xref ref-type="bibr" rid="b11-jnc-230018">11</xref>,<xref ref-type="bibr" rid="b12-jnc-230018">12</xref>&#x0005d;. Therefore, as in this case report, AVMs with genetic predispositions require active surveillance with a tailored prediction of rupture and preemptive intervention. Extensive cerebral vasculopathy can occur even in childhood and is life-threatening if not adequately addressed.</p>
</sec>
</body>
<back>
<fn-group>
<fn><p><bold>Ethics statement</bold></p><p>This study was approved by the Institutional Review Board of St. Mary's Hospital (No. KC23ZASI0322). The requirement of informed consent was waived.</p></fn>
<fn fn-type="conflict"><p><bold>Conflict of interest</bold></p><p>No potential conflict of interest relevant to this article.</p></fn>
<fn fn-type="participating-researchers"><p><bold>Author contributions</bold></p>
<p>Conceptualization: EK, SWY. Data curation: EK, SWY. Writing–original draft: EK, SWY. Writing–review &amp; editing: EK, IJH, JWK, JSL, DEJ, SWY.</p></fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-jnc-230018">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nix</surname><given-names>JS</given-names></name>
<name><surname>Blakeley</surname><given-names>J</given-names></name>
<name><surname>Rodriguez</surname><given-names>FJ</given-names></name>
</person-group>
<article-title>An update on the central nervous system manifestations of neurofibromatosis type 1</article-title>
<source>Acta Neuropathol</source>
<year>2020</year>
<volume>139</volume>
<fpage>625</fpage>
<lpage>41</lpage>
</element-citation></ref>
<ref id="b2-jnc-230018">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Barreto-Duarte</surname><given-names>B</given-names></name>
<name><surname>Andrade-Gomes</surname><given-names>FH</given-names></name>
<name><surname>Arriaga</surname><given-names>MB</given-names></name>
<name><surname>Ara&#x000fa;jo-Pereira</surname><given-names>M</given-names></name>
<name><surname>Cubillos-Angulo</surname><given-names>JM</given-names></name>
<name><surname>Andrade</surname><given-names>BB</given-names></name>
</person-group>
<article-title>Association between neurofibromatosis type 1 and cerebrovascular diseases in children: a systematic review</article-title>
<source>PLoS One</source>
<year>2021</year>
<volume>16</volume>
<fpage>e0241096</fpage>
</element-citation></ref>
<ref id="b3-jnc-230018">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gutmann</surname><given-names>DH</given-names></name>
<name><surname>Ferner</surname><given-names>RE</given-names></name>
<name><surname>Listernick</surname><given-names>RH</given-names></name>
<name><surname>Korf</surname><given-names>BR</given-names></name>
<name><surname>Wolters</surname><given-names>PL</given-names></name>
<name><surname>Johnson</surname><given-names>KJ</given-names></name>
</person-group>
<article-title>Neurofibromatosis type 1</article-title>
<source>Nat Rev Dis Primers</source>
<year>2017</year>
<volume>3</volume>
<fpage>17004</fpage>
</element-citation></ref>
<ref id="b4-jnc-230018">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Monroe</surname><given-names>CL</given-names></name>
<name><surname>Dahiya</surname><given-names>S</given-names></name>
<name><surname>Gutmann</surname><given-names>DH</given-names></name>
</person-group>
<article-title>Dissecting clinical heterogeneity in neurofibromatosis type 1</article-title>
<source>Annu Rev Pathol</source>
<year>2017</year>
<volume>12</volume>
<fpage>53</fpage>
<lpage>74</lpage>
</element-citation></ref>
<ref id="b5-jnc-230018">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vogel</surname><given-names>AC</given-names></name>
<name><surname>Gutmann</surname><given-names>DH</given-names></name>
<name><surname>Morris</surname><given-names>SM</given-names></name>
</person-group>
<article-title>Neurodevelopmental disorders in children with neurofibromatosis type 1</article-title>
<source>Dev Med Child Neurol</source>
<year>2017</year>
<volume>59</volume>
<fpage>1112</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b6-jnc-230018">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zessis</surname><given-names>NR</given-names></name>
<name><surname>Gao</surname><given-names>F</given-names></name>
<name><surname>Vadlamudi</surname><given-names>G</given-names></name>
<name><surname>Gutmann</surname><given-names>DH</given-names></name>
<name><surname>Hollander</surname><given-names>AS</given-names></name>
</person-group>
<article-title>Height growth impairment in children with neurofibromatosis type 1 is characterized by decreased pubertal growth velocity in both sexes</article-title>
<source>J Child Neurol</source>
<year>2018</year>
<volume>33</volume>
<fpage>762</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b7-jnc-230018">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Terry</surname><given-names>AR</given-names></name>
<name><surname>Jordan</surname><given-names>JT</given-names></name>
<name><surname>Schwamm</surname><given-names>L</given-names></name>
<name><surname>Plotkin</surname><given-names>SR</given-names></name>
</person-group>
<article-title>Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: population-based approach</article-title>
<source>Stroke</source>
<year>2016</year>
<volume>47</volume>
<fpage>60</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b8-jnc-230018">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaas</surname><given-names>B</given-names></name>
<name><surname>Huisman</surname><given-names>TA</given-names></name>
<name><surname>Tekes</surname><given-names>A</given-names></name>
<name><surname>Bergner</surname><given-names>A</given-names></name>
<name><surname>Blakeley</surname><given-names>JO</given-names></name>
<name><surname>Jordan</surname><given-names>LC</given-names></name>
</person-group>
<article-title>Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1</article-title>
<source>J Child Neurol</source>
<year>2013</year>
<volume>28</volume>
<fpage>561</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b9-jnc-230018">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bargiela</surname><given-names>D</given-names></name>
<name><surname>Verkerk</surname><given-names>MM</given-names></name>
<name><surname>Wee</surname><given-names>I</given-names></name>
<name><surname>Welman</surname><given-names>K</given-names></name>
<name><surname>Ng</surname><given-names>E</given-names></name>
<name><surname>Choong</surname><given-names>AM</given-names></name>
</person-group>
<article-title>The endovascular management of neurofibromatosis-associated aneurysms: a systematic review</article-title>
<source>Eur J Radiol</source>
<year>2018</year>
<volume>100</volume>
<fpage>66</fpage>
<lpage>75</lpage>
</element-citation></ref>
<ref id="b10-jnc-230018">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Puschmann</surname><given-names>A</given-names></name>
<name><surname>Wszolek</surname><given-names>ZK</given-names></name>
</person-group>
<article-title>Diagnosis and treatment of common forms of tremor</article-title>
<source>Semin Neurol</source>
<year>2011</year>
<volume>31</volume>
<fpage>65</fpage>
<lpage>77</lpage>
</element-citation></ref>
<ref id="b11-jnc-230018">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H</given-names></name>
<name><surname>Al-Shahi Salman</surname><given-names>R</given-names></name>
<name><surname>McCulloch</surname><given-names>CE</given-names></name>
<name><surname>Stapf</surname><given-names>C</given-names></name>
<name><surname>Young WL; MARS</surname><given-names>Coinvestigators</given-names></name>
</person-group>
<article-title>Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors</article-title>
<source>Neurology</source>
<year>2014</year>
<volume>83</volume>
<fpage>590</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b12-jnc-230018">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Germans</surname><given-names>MR</given-names></name>
<name><surname>Sun</surname><given-names>W</given-names></name>
<name><surname>Seb&#x000f6;k</surname><given-names>M</given-names></name>
<name><surname>Keller</surname><given-names>A</given-names></name>
<name><surname>Regli</surname><given-names>L</given-names></name>
</person-group>
<article-title>Molecular signature of brain arteriovenous malformation hemorrhage: a systematic review</article-title>
<source>World Neurosurg</source>
<year>2022</year>
<volume>157</volume>
<fpage>143</fpage>
<lpage>51</lpage>
</element-citation></ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-jnc-230018" position="float">
<label>Fig. 1.</label><caption><p>Transfemoral cerebral angiography (TFCA) at age 15 years revealed asymmetric moyamoya vessels of (A) Suzuki grading III of the left and (B) VI of the right hemisphere, and (C) right cerebellar arteriovenous malformation (main feeder: right posterior inferior cerebellar artery; red arrow). (D) Postoperative TFCA; the superficial temporal artery-middle cerebral artery bypass flow (bypass conduit; red arrow) was well-preserved after 13 years.</p></caption>
<graphic xlink:href="jnc-230018f1.tif"/>
</fig>
<fig id="f2-jnc-230018" position="float">
<label>Fig. 2.</label><caption><p>Transfemoral cerebral angiography at the time of rupture unveiled (A) three right anterior and posterior inferior cerebellar arteries and superior cerebellar artery supplying the vascular tuft, and (B) two were successfully embolized except posterior inferior cerebellar artery with residual flows (red arrow). Brain T2 weighted resonance imaging of the right infratentorial arteriovenous malformation displayed (C) the ruptured hemorrhage within its nidus at the initial and (D) partial resolution after 6 months.</p></caption>
<graphic xlink:href="jnc-230018f2.tif"/>
</fig>
</sec>
</back></article>